Financials
- Market Capitalization 202.53 M
- Employee 29
- Founded 2014
- CEO N/A
- Website www.cuebiopharma.com
- Headquarter Delaware, United States
- FIGI BBG00FVMPFN7
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.09
Relación precio/flujo de caja
1.07
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3597 | IPHA Innate Pharma S.A. - American Depositary Shares | 2.23 USD | 0.00% | +0.90% | +27.43% | +7.21% | 208.99 M USD | ||
| 3610 | PLX Protalix BioTherapeutics, Inc. Common Stock | 2.53 USD | -3.07% | +6.75% | +11.45% | -13.36% | 203.85 M USD | ||
| 3622 | ACOG Alpha Cognition Inc. - Common Stock | 9.16 USD | -5.95% | -5.76% | +3.97% | +9.96% | 199.49 M USD | ||
| 3623 | NKTX Nkarta, Inc. - Common Stock | 2.76 USD | +0.36% | +5.34% | +28.97% | +28.37% | 197.68 M USD |